The Archer® FusionPlex® Lymphoma Kit is a targeted next generation sequencing assay to simultaneously detect and identify fusions, point mutations, and expression levels in 125 genes linked to lymphomas.
Studies are performed from RNA extracted from several types of starting sample. Using Archer’s proprietary Anchored Multiplex PCR (AMP™)-based enrichment, fusions of all genes in this kit can be identified in a single sequencing assay, even without prior knowledge of fusion partners or breakpoints.
Archer Analysis software allows the analysis and interpretation of the data.
Genes:
